Aim & Scope
Cancer is a devastating disease that causes one in six deaths globally. A large proportion of these deaths could be prevented, but improving prevention and treatment outcomes requires accurate diagnosis, the development of effective and precise treatment modalities and a better understanding of the socioeconomic factors that affect cancer incidence, prevalence and mortality. Nature Cancer aims to provide a unique forum through which the cancer community will learn about the latest, most significant cancer-related advances across the life, physical, applied and social sciences. Areas of interest include fundamental, preclinical research that furthers our understanding of the mechanisms underlying tumour initiation, propagation and progression; work aiming to translate this knowledge to the clinic by focusing on new approaches for the development and delivery of diagnostic and therapeutic modalities; clinical studies informing cancer diagnosis, treatment and prevention; and new ways of understanding the global societal impact of cancer. In addition to publishing original research, Nature Cancer will publish Comments, Reviews, News & Views, Features and Correspondence of high significance across the range of disciplines relating to cancer research. Topics covered in the journal include: Cancer biology, encompassing oncogenic and tumour-suppressive mechanisms that deregulate molecular pathways and cellular processes, including tumour-initiating cells/cancer stem cells; Cancer genetics and genomics, including functional genomics and the mechanisms underlying genome integrity, genomic instability and mutation; Tumour evolution and heterogeneity; Tumour–host interactions, including the tumour microenvironment (molecular, cellular, physical) and systemic effects; Tumour immunology and immunotherapy; Metastasis, including mechanisms of cancer cell dissemination, seeding, dormancy and growth in secondary sites; Therapy, including design and delivery, targeted, combination and precision therapy and the study of therapy resistance; Clinical work that informs cancer diagnosis, treatment and prevention; Cancer models and methodology to investigate, diagnose and treat cancer; Systems biology, including large-scale and single-cell omics and multi-omics approaches to characterise and study cancer; Social, ethical and policy issues relating to cancer research, prevention, diagnosis and treatment. [1]
Series / Collection
0028-0836 ( Print )
1476-4687 ( Online )
Nature Research
,
Springer
2157-846X ( Online )
Nature Research
,
Springer
1087-0156 ( Print )
1546-1696 ( Online )
Nature Research
,
Springer
2731-0590 ( Online )
Nature Research
,
Springer
1465-7392 ( Print )
1476-4679 ( Online )
Nature Research
,
Springer
2024
Multidimensional analysis reveals predictive markers for CAR-T efficacy.
Nature Cancer , 2024
Editorial Retractions, Expressions of Concern and External Notices
GAP43-dependent mitochondria transfer from astrocytes enhances glioblastoma tumorigenicity
DC Watson , D Bayik , S Storevik , ... , JD Lathia
Nature Cancer2023 - VOLUME 4, ISSUE 5 pp 648-664.
31 68
M Manczinger , B Koncz , GM Balogh , ... , C Pál
Nature Cancer2021 - VOLUME 2, ISSUE 9 pp 950-961.
12 87
L Haas , A Elewaut , CL Gerard , ... , AC Obenauf
Nature Cancer2021 - VOLUME 2, ISSUE 7 pp 693-708.
76 65
L1CAM defines the regenerative origin of metastasis-initiating cells in colorectal cancer.
K Ganesh , H Basnet , Y Kaygusuz , ... , J Massagué
Nature Cancer2020 - VOLUME 1, ISSUE 1 pp 28-45.
115 79